Neophyr (Nitric Oxide)

Nitric Oxide, the active ingredient in Neophyr, is a medical gas presented as an inhalation gas for inhalation use. It acts as a vasodilator to improve pulmonary blood flow in conditions such as pulmonary hypertension and acute respiratory distress. GNH USA supplies Neophyr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Neophyr is used as an inhaled vasodilator in several pulmonary conditions. - Neonatal pulmonary hypertension: improves oxygenation and reduces right‑ventricular strain. - Acute respiratory distress syndrome (ARDS): lowers pulmonary artery pressure and enhances gas exchange. - Cardiopulmonary bypass surgery: prevents intra‑operative pulmonary hypertension and supports postoperative recovery.

Inhaled nitric oxide can produce a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Hypotension: transient drop in systemic blood pressure. - Methemoglobinemia: elevated methemoglobin levels reducing oxygen delivery. - Rebound pulmonary hypertension: occurs upon abrupt discontinuation. - Nitrogen dioxide formation: irritant gas if concentrations are high. - Headache: mild and self‑limiting. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: may require vasopressor support. - Severe methemoglobinemia: can cause cyanosis and requires treatment. - Toxic nitrogen dioxide exposure: leads to airway irritation. - Bleeding complications: especially in patients on anticoagulants. - Infection risk: if delivery system becomes contaminated. - Pulmonary edema: rare but serious respiratory compromise.

When using Neophyr, clinicians should follow established safety protocols. - Dose titration: adjust based on oxygenation response and blood pressure. - Monitoring: continuous pulse oximetry and methemoglobin measurement are essential. - Contraindications: avoid in patients with severe anemia or known hypersensitivity to nitric oxide. - Pregnancy: use only if potential benefit outweighs risk to the fetus. - Drug interactions: be cautious when co‑administered with other vasodilators. - Store at ambient temperature: keep cylinder in original container, protect from heat and direct sunlight.

Nitric Oxide may interact with several agents that affect vascular tone or oxidative pathways.

Major Interactions (Avoid): - Other inhaled nitric oxide sources: risk of cumulative overdose. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): additive pulmonary vasodilation. - Nitroglycerin: may cause excessive hypotension.

Moderate Interactions (Monitor Closely): - Inhaled anesthetics: potential potentiation of blood pressure lowering. - Bronchodilators: may alter pulmonary response to nitric oxide. - Anticoagulants: monitor for increased bleeding tendency.